Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David A. Ramsay currently holds 10,000 shares of HALOZYME THERAPEUTICS INC (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David A. Ramsay has been a net buyer of HALO stock. They have purchased $4.0M and sold $423.0K worth of shares.
David A. Ramsay's most recent insider trade was on Apr 1, 2026, when they sold 10,000 shares at $0.00 per share.
David A. Ramsay serves as Executive at HALOZYME THERAPEUTICS INC (HALO). They have executed 191 insider transactions totaling $4.4M over their tenure at the company.
David A. Ramsay holds the position of Executive at HALOZYME THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
David A. Ramsay has shown a buying trading pattern, with $4.0M in total purchases and $423.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David A. Ramsay was on Aug 22, 2022, when they sold $623.0K worth of LJPC shares. This transaction involved 100,000 shares at $6.23 per share.
David A. Ramsay currently owns 10,000 shares of HALOZYME THERAPEUTICS INC (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David A. Ramsay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David A. Ramsay has 191 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS INC.
Set alerts for David A. Ramsay and 40,000+ other insiders.